Article title efficacy and safety of romosozumab in postmenopausal women with osteoporosis previously treated with antiresorptive drugs: a prospective observational study and literature review. [PDF]
Front Glob Womens HealthYamamoto M +12 more
europepmc +1 more source
Real-world pharmacovigilance of drug-related bone metabolism disorders: integrating FAERS and VigiAccess with a Bradford Hill-based causal plausibility assessment. [PDF]
Front PharmacolLiu P +5 more
europepmc +1 more source
Nitrogen-Based Bisphosphonate Use and Risk of Cancer in Women Aged 50 Years and Older: A National Data Linkage Study. [PDF]
Int J CancerTuesley KM +7 more
europepmc +1 more source
Geranylgeraniol as a Modulator of Mevalonate Pathway Disruption: A Scoping Review of Cellular Mechanisms and Skeletal Outcomes in Osteoporosis Models. [PDF]
Pharmaceuticals (Basel)Ekeuku SO +4 more
europepmc +1 more source
Potent bisphosphonate therapy for preventing fractures after denosumab discontinuation in osteoporosis: A GRADE-assessed systematic review and meta-analysis. [PDF]
Medicine (Baltimore)Shah A +10 more
europepmc +1 more source
Osteoclast-derived exosomes promote medication-related osteonecrosis of the jaw by delivering glycoRNA to disrupt the blood-lymphatic vascular network. [PDF]
J Dent SciZhang J, Tao J, Zhao C, Pan J.
europepmc +1 more source
The Bisphosphonate Accumulation Index (BAI): A Quantitative Metric for Cumulative Antiresorptive Exposure in Pre-Procedural Dental and Surgical Assessment. [PDF]
Dent J (Basel)Zecca PA +5 more
europepmc +1 more source
Longitudinal osteoporosis therapy: treat-to-target and sequential strategies-a narrative review. [PDF]
Ther Adv Musculoskelet DisTskhakaia I, Danila MI.
europepmc +1 more source